Thursday

9th Apr 2020

Something 'rotten' in EU pharmaceutical sector, says Kroes

  • The commission report points to widespread collusion between European drug makers (Photo: www.freeimages.co.uk)

European competition commissioner Neelie Kroes turned to Shakespeare on Wednesday (8 July) to describe anti-competition practices being widely used by pharmaceutical companies throughout the European union.

"Overall it is indeed a conclusion that there is something rotten in the state," she said, paraphrasing comments made by the character Marcellus in Act I of the British playwright's famous work, Hamlet.

Read and decide

Join EUobserver today

Support quality EU news

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

Ms Kroes made the statement following the publication of a final inquiry report on Europe's pharmaceutical sector – a document that points to widespread collusion between drug companies producing original products and others producing generic copies.

According to the report, a considerable number of generic drug producers have accepted payments to delay the release of medicines that are on average 40 percent cheaper than the original product two years after its initial release.

Sending a clear signal that it means to crack down on the practice that results in European citizens paying more for their medicines, the commission has opened a formal antitrust investigation against French company Les Laboratoires Servier and a number of generic drug producers suspected of collusion.

"When it comes to generic entry, every week and month of delay costs money to patients and taxpayers. We will not hesitate to apply the antitrust rules where such delays result from anticompetitive practices," said Ms Kroes.

The case, the first of its kind, surrounds the production of a generic form of perindopril, a cardiovascular medicine used to prevent heart disease and lower blood pressure originally developed by Servier.

The commission says it has evidence of a least a further 200 incidences of illegal agreements between European drug companies, all of which could lead to fines if sufficient evidence is found.

"We hoped to get out a case that is really damaging," said Ms Kroes when asked why the commission had concentrated its first case on Servier and not on other suspected companies, some of which are considerably bigger.

The debate over artificially inflated drug prices is particularly relevant at present as Europe's population grows older and the prospects for both private and public pensions look shakier due to the financial crisis.

"With the ageing population we are going to need more medicine," said Ms Kroes.

European citizens currently spend €214 billion per year on pharmaceuticals, equivalent to 2 percent of the bloc's total GDP or €430 per year per citizen.

The commission report also calls on member states to introduce legislation to facilitate the uptake of generic drugs and says a community patent and specialised patent litigation system in Europe is now more necessary than ever.

At present 30 percent of patent court cases are conducted in parallel in several member states, and in 11 percent of cases national courts reach conflicting judgements.

Opinion

Why are our medicines so expensive?

The EU should be promoting open innovation in upcoming trade talks with India and should work to bring down the prices of essential medicines, both abroad and within its borders.

Opinion

Why Europe must act now, and on a big scale

It is still very likely that Europe will face a new deadly spread of the virus next autumn or winter. Until a reliable vaccine and cure are in place, we all have to live in this new reality.

Opinion

Coronavirus sees approval-rating soar for EU leaders

The rise in support for mainstream parties has been paired with stagnation or decline for far-right populist parties and figures - the AfD has dropped to 10 percent in Germany and Marine Le Pen and Matteo Salvini are treading water.

Coronavirus

EU science chief who 'quit' had been told to resign

Contested version of events cloud the shock resignation of Mauro Ferrari as president of the European Research Council. Ferrari dramatically tendered his resignation on 7 April. But his colleagues overseeing the council wanted him gone already by late March.

Coronavirus

EU delays 'exit strategies' plan, as WHO urges caution

The European Commission dropped plans to unveil a "roadmap" to end restrictive measures imposed by member states. Meanwhile, the World Health Organization warned countries not to lift restrictions prematurely.

News in Brief

  1. IMF: Pandemic crisis will be worse than great depression
  2. German economy minister expects progress on EU deal
  3. Italian PM: EU is at risk if no deal on recovery plan
  4. Belgian region to block EU Green Deal
  5. EU commission launches green finance consultation
  6. EU parliament kitchens to cook for homeless
  7. EU sets aside €15.6bn for virus fight in Africa and beyond
  8. CO2 emissions from EU plunge 60 percent

Opinion

Coronavirus sees approval-rating soar for EU leaders

The rise in support for mainstream parties has been paired with stagnation or decline for far-right populist parties and figures - the AfD has dropped to 10 percent in Germany and Marine Le Pen and Matteo Salvini are treading water.

Stakeholders' Highlights

  1. UNESDAMaking Europe’s Economy Circular – the time is now
  2. Nordic Council of MinistersScottish parliament seeks closer collaboration with the Nordic Council
  3. UNESDAFrom Linear to Circular – check out UNESDA's new blog
  4. Nordic Council of Ministers40 years of experience have proven its point: Sustainable financing actually works
  5. Nordic Council of MinistersNordic and Baltic ministers paving the way for 5G in the region
  6. Nordic Council of MinistersEarmarked paternity leave – an effective way to change norms

Latest News

  1. Why Europe must act now, and on a big scale
  2. EU court blocks Poland's bid to 'frighten' judges
  3. Coronavirus sees approval-rating soar for EU leaders
  4. EU science chief who 'quit' had been told to resign
  5. EU delays 'exit strategies' plan, as WHO urges caution
  6. EU stalemate after 16-hour meeting on economic aid
  7. The future of 'Made in China' after coronavirus?
  8. Refugees across Europe help fight the pandemic

Join EUobserver

Support quality EU news

Join us